About mentioning quality of preparation and quality control of radiopharmaceuticals used in nuclear medicine procedures [3]
dc.contributor.author | Wozniak, Greta | en |
dc.contributor.author | Georgoulias, Panagiotis | en |
dc.contributor.author | Archimandritis, Spiros | en |
dc.contributor.author | Dimakopoulos, Nikolaos | en |
dc.contributor.author | Fezoulidis, Ioannis | en |
dc.creator | Wozniak, Greta | en |
dc.creator | Georgoulias, Panagiotis | en |
dc.creator | Archimandritis, Spiros | en |
dc.creator | Dimakopoulos, Nikolaos | en |
dc.creator | Fezoulidis, Ioannis | en |
dc.date.accessioned | 2018-06-22T09:53:27Z | |
dc.date.available | 2018-06-22T09:53:27Z | |
dc.date.issued | 2006 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/41844 | |
dc.language.iso | eng | en |
dc.source | Hellenic Journal of Nuclear Medicine | en |
dc.subject | Guidelines | en |
dc.subject | Human | en |
dc.subject | Letter | en |
dc.subject | Drug half life | en |
dc.subject | High performance liquid chromatography | en |
dc.subject | Inflammation | en |
dc.subject | Allergic reaction | en |
dc.subject | Thallium 201 | en |
dc.subject | Radiation dose | en |
dc.subject | Technetium 99m | en |
dc.subject | Quality control | en |
dc.subject | Radiopharmaceutical agent | en |
dc.subject | Radiopharmaceuticals | en |
dc.subject | Rhenium 186 | en |
dc.subject | Rhenium 188 | en |
dc.subject | Samarium 153 | en |
dc.subject | Yttrium 90 | en |
dc.subject | Cyclotron | en |
dc.subject | Drug contamination | en |
dc.subject | Drug impurity | en |
dc.subject | Drug manufacture | en |
dc.subject | Drug purity | en |
dc.subject | Drug sterility | en |
dc.subject | Drug synthesis | en |
dc.subject | Electrophoresis | en |
dc.subject | Fission neutron | en |
dc.subject | Gallium 67 | en |
dc.subject | Gel filtration | en |
dc.subject | Generator | en |
dc.subject | Health care | en |
dc.subject | Image quality | en |
dc.subject | Indium 111 | en |
dc.subject | Internationality | en |
dc.subject | Iodine 123 | en |
dc.subject | Iodine 131 | en |
dc.subject | Isotope labeling | en |
dc.subject | Molybdenum 99 | en |
dc.subject | Nuclear medicine | en |
dc.subject | Nuclear reactor | en |
dc.subject | Quality assurance | en |
dc.subject | Radiation protection | en |
dc.subject | Radioactivity | en |
dc.subject | Radiochromatography | en |
dc.subject | Solvent extraction | en |
dc.title | About mentioning quality of preparation and quality control of radiopharmaceuticals used in nuclear medicine procedures [3] | en |
dc.type | info:eu-repo/semantics/article | |
dc.description.volume | 9 | |
dc.description.issue | 1 | |
dc.description.startingpage | 41 | |
dc.description.endingpage | 42 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Wozniak, Greta [0000-0002-8939-0927] | |
dc.contributor.orcid | Georgoulias, Panagiotis [0000-0002-6493-705X] | |
dc.gnosis.orcid | 0000-0002-8939-0927 | |
dc.gnosis.orcid | 0000-0002-6493-705X |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |